U.S. federal trademark · Serial No. 74390693 · Reg. No. 2018036
pharmaceutical preparations for the prevention, control and treatment of organ graft rejection, graft versus host disease, auto-immune diseases, asthma, crohn's disease, tumors, adhesions, scarring, scleroderma, psoriasis, allogeneic bone [ morrow ] * marrow * transplant rejection, toxicity from chemotherapy, AIDS, ARC, and for use in vitamin therapy, including vitamin depletion; vitamins; and coenzymes
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.